Dow Jones
38.024,24 -436,68 (-1,14%) Nasdaq
15.556,92 -155,83 (-0,99%) Nikkei 225
37.628,48 -831,60 (-2,16%) EUR/USD
1,0737 +0,0036 (+0,33%) Bitcoin EUR
60.154,23 -228,08 (-0,38%) CMC Crypto 200
1.390,58 +8,01 (+0,58%)
Aspira Women's Health Inc. (AWH)
| Chiusura precedente | 3,3600 |
| Aperto | 3,3500 |
| Denaro | 0,0000 x 0 |
| Lettera | 0,0000 x 0 |
| Min-Max giorno | 3,2000 - 3,3800 |
| Intervallo di 52 settimane | 2,3100 - 6,7500 |
| Volume | |
| Media Volume | 25.243 |
| Capitalizzazione | 41,723M |
| Beta (5 anni mensile) | 1,61 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -1,8100 |
| Prossima data utili | 09 mag 2024 - 13 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 5,25 |
GlobeNewswireAspira Women’s Health to Present at the BioVenture Nexus Conference
The conference is taking place on October 5-6, 2023, in Los Angeles, CAAUSTIN, Texas, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, today announced that Nicole Sandford, Chief Executive Officer, will present a brief corporate overview at the BioVenture Nexus Conference at 4:30 pm PDT on October 5, 2023. T
- GlobeNewswire
Aspira Women’s Health Regains Nasdaq Compliance
AUSTIN, Texas, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, today announced that it received written notice from the Nasdaq Stock Market LLC (“NASDAQ”) on September 12, 2023 informing the Company that it has regained compliance with the market value of listed securities (“MVLS”) requirement, as set forth
- GlobeNewswire
Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer
AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, today announced it has named Jody Berry, Ph.D. as its new Chief Scientific Officer. Dr. Ryan Phan, who stepped down as the Company’s Chief Scientific and Operating Officer, remains as an advisor through the end of the year to help with the trans
